The 11th BioCon China Expo 2024 will grandly open in China National Convention Center in April, and it will upgrade and expand in all aspects, such as exhibition scale, variety of exhibits, participants, and concurrent activities. In 2024, it marks a new starting point for the second decade of the BioCon China Expo. Based on the accumulation of industry advantages and resources over the years, the exhibition will expand to nearly 20000 square meters , fully extending the industry upstream and downstream, gathering strength for the industry, and creating an innovative biomedical technology exhibition with "Professional Exhibition + Biopharmaceutical Industry Forum + Exclusive Authoritative Competition + Special Activities in Exhibition Area" as a whole.

“Intense homogenized competition, exacerbated industry competition, tightened upstream capital, lack of original research and development, inadequate talent reserves...” In this rapidly changing post-pandemic era, how can the biopharmaceutical industry confront these new challenges and make breakthroughs?” The BioCon China Expo 2024  takes "Adapting to Changes, and Pursuing Excellence"as the theme of this annual conference. The BioLeader forum will grasp the new trends in the development of the bio-pharmaceutical industry, promote new cooperation between the upstream and downstream of the industry chain, and set new standards for investment and financing. The specialized seminars comprehensively cover hot topics in the field of bio-pharmaceuticals: nucleic acid drugs, gene therapy, cell therapy, antibody drugs, chemical drugs, synthetic biology, etc., from research and development innovation to commercial production throughout the entire life cycle, promoting high-quality development of the industry.

Currently, booth reservations for the 2024 event are in full swing, with 70% of the previous exhibitors already booked.

BRAND HISTORY

The BioCon conference was born in 2014 and has accompanied the “pharmaceutical people” through the ups and downs of the past 9 years. 

Originating in Wuhan, developed in Shanghai, and rooted in Hangzhou, it has grown into one of the longest-running domestic biopharmaceutical brand conferences over the past 10 years. It has witnessed the early entrepreneurship of returned overseas Chinese, and always accompanying the development and growth of China’s biopharmaceutical companies. Currently, BioCon China has accumulated over 30,000 participants from senior professionals in the global biopharmaceutical industry, and over 800 industry-leading service and product providers have sponsored the conference eagerly. A total of over 1,100 industry leaders participated in expert speeches, sharing, and discussions.